XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Jun. 30, 2023
ASSETS    
Cash and cash equivalents $ 4,285,343 $ 5,619,083
Accounts receivable 975,172 1,453,770
Deferred costs/contract assets 72,205 158,552
Prepaid expenses and other current assets 813,193 562,163
Total current assets 6,145,913 7,793,568
Equipment, net 184,954 264,451
Right-of-use assets, net 522,449 627,832
Intangible assets, net 2,820,068 4,284,151
Goodwill 10,857,600 11,236,638
Other assets 73,273 71,767
Total assets 20,604,257 24,278,407
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 241,072 455,777
Accrued liabilities 246,971 635,616
Accrued non cash performance bonus 1,041,596
Deferred revenue/contract liabilities 69,847 466,393
Lease liabilities, current portion 413,237 405,948
Contingent consideration for acquisitions, current portion 2,918,939 5,120,791
Total current liabilities 3,890,066 8,126,121
Long term liabilities    
Contingent consideration for acquisitions, net of current portion 1,414,682 4,505,000
Lease liabilities, net of current portion 211,638 423,454
Total liabilities 5,516,386 13,054,575
Commitments and contingencies
Stockholders’ Equity    
Preferred Stock, par value $0.001 per share, 20 million shares authorized; 0 shares issued and outstanding
Common Stock, par value $0.001 per share, 300 million shares authorized; 18,140,217 and 14,701,929 issued and outstanding, respectively 18,141 14,702
Additional paid-in capital 74,114,774 67,854,108
Accumulated deficit (59,045,044) (56,644,978)
Total stockholders’ equity 15,087,871 11,223,832
Total liabilities and stockholders’ equity $ 20,604,257 $ 24,278,407